-
1
-
-
0035820265
-
MULTIVIRC Group : Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study
-
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T - MULTIVIRC Group : Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study. Lancet 2001 ; 357 : 1069-75
-
(2001)
Lancet
, vol.357
, pp. 1069-1075
-
-
Imbert-Bismut, F.1
Ratziu, V.2
Pieroni, L.3
Charlotte, F.4
Benhamou, Y.5
Poynard, T.6
-
2
-
-
0042265556
-
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
-
Wai CT, Greenson JK, Fontana RJ et al. : A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 ; 38 : 518-26
-
(2003)
Hepatology
, vol.38
, pp. 518-526
-
-
Wai, C.T.1
Greenson, J.K.2
Fontana, R.J.3
-
3
-
-
0036789328
-
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
-
Forns X, Ampurdanes S, Llovet JM et al. : Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002 ; 36 : 986-92
-
(2002)
Hepatology
, vol.36
, pp. 986-992
-
-
Forns, X.1
Ampurdanes, S.2
Llovet, J.M.3
-
4
-
-
33745547388
-
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
-
Sterling RK, Lissen E, Clumeck N et al. : Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 ; 43 : 1317-25
-
(2006)
Hepatology
, vol.43
, pp. 1317-1325
-
-
Sterling, R.K.1
Lissen, E.2
Clumeck, N.3
-
5
-
-
33847705375
-
FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C
-
Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y : FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007 ; 45 : 297-306
-
(2007)
Hepatology
, vol.45
, pp. 297-306
-
-
Koda, M.1
Matunaga, Y.2
Kawakami, M.3
Kishimoto, Y.4
Suou, T.5
Murawaki, Y.6
-
6
-
-
12344309018
-
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
-
Castera L, Vergniol J, Foucher J et al. : Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 ; 128 : 343-50
-
(2005)
Gastroenterology
, vol.128
, pp. 343-350
-
-
Castera, L.1
Vergniol, J.2
Foucher, J.3
-
7
-
-
35148812777
-
-
The HAS recommendations for the management of the chronic hepatitis C using non-invasive biomarkers 19/01/2007
-
The HAS recommendations for the management of the chronic hepatitis C using non-invasive biomarkers 19/01/2007 - http://www.has-sante.fr/portail/ display.jsp?id=c_476504
-
-
-
-
8
-
-
0029778988
-
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
-
Bedossa P, Poynard T : An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 ; 24 : 289-93
-
(1996)
Hepatology
, vol.24
, pp. 289-293
-
-
Bedossa, P.1
Poynard, T.2
-
9
-
-
33947428441
-
Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD)
-
Kamath PS, Kim WR : Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007 ; 45 : 797-805
-
(2007)
Hepatology
, vol.45
, pp. 797-805
-
-
Kamath, P.S.1
Kim, W.R.2
-
10
-
-
33751248252
-
Direct and indirect evidence for the reversibility of cirrhosis
-
Serpaggi J, Carnot F, Nalpas B et al. : Direct and indirect evidence for the reversibility of cirrhosis. Hum Pathol 2006 ; 37 : 1519-26
-
(2006)
Hum Pathol
, vol.37
, pp. 1519-1526
-
-
Serpaggi, J.1
Carnot, F.2
Nalpas, B.3
-
11
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
Chen CJ, Yang HI, Su J et al. : Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 ; 295 : 65-73
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
-
12
-
-
19544391413
-
Lamivudine for patients with chronic hepatitis B and advanced liver disease
-
Liaw YF, Sung JJ, Chow WC et al. : Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004 ; 351 : 1521-31
-
(2004)
N Engl J Med
, vol.351
, pp. 1521-1531
-
-
Liaw, Y.F.1
Sung, J.J.2
Chow, W.C.3
-
13
-
-
33845636037
-
-
New treatment strategies against hepatitis C viral infection. Can J Gastroenterol 2006 ; 20 : 735-9
-
New treatment strategies against hepatitis C viral infection. Can J Gastroenterol 2006 ; 20 : 735-9
-
-
-
-
14
-
-
33745283424
-
Non alcoholic fatty liver disease : A clinical approach and review
-
Raman M, Allard J : Non alcoholic fatty liver disease : a clinical approach and review. Can J Gastroenterol 2006 ; 20 : 345-9
-
(2006)
Can J Gastroenterol
, vol.20
, pp. 345-349
-
-
Raman, M.1
Allard, J.2
-
15
-
-
33645536593
-
Treatment of non-alcoholic fatty liver disease
-
Adams LA, Angulo P : Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006 ; 82 : 315-22
-
(2006)
Postgrad Med J
, vol.82
, pp. 315-322
-
-
Adams, L.A.1
Angulo, P.2
-
16
-
-
33747047274
-
Statins and hepatic steatosis : Perspectives from the Dallas Heart Study
-
Browning JD : Statins and hepatic steatosis : perspectives from the Dallas Heart Study. Hepatology 2006 ; 44 : 466-71
-
(2006)
Hepatology
, vol.44
, pp. 466-471
-
-
Browning, J.D.1
-
17
-
-
21344453508
-
Autoimmune hepatitis : Effect of symptoms and cirrhosis on natural history and outcome
-
Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ : Autoimmune hepatitis : effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005 ; 42 : 53-62
-
(2005)
Hepatology
, vol.42
, pp. 53-62
-
-
Feld, J.J.1
Dinh, H.2
Arenovich, T.3
Marcus, V.A.4
Wanless, I.R.5
Heathcote, E.J.6
-
18
-
-
33747507619
-
Medical treatment of cholestatic liver diseases : From pathobiology to pharmacological targets
-
Review
-
Paumgartner G : Medical treatment of cholestatic liver diseases : From pathobiology to pharmacological targets. World J Gastroenterol 2006 ; 12 : 4445-51 Review
-
(2006)
World J Gastroenterol
, vol.12
, pp. 4445-4451
-
-
Paumgartner, G.1
-
19
-
-
33747042226
-
Reversibility of hepatic fibrosis in treated genetic hemochromatosis : A study of 36 cases
-
Falize L, Guillygomarc'h A, Perrin M et al. : Reversibility of hepatic fibrosis in treated genetic hemochromatosis : a study of 36 cases. Hepatology 2006 ; 44 : 472-7
-
(2006)
Hepatology
, vol.44
, pp. 472-477
-
-
Falize, L.1
Guillygomarc'h, A.2
Perrin, M.3
-
21
-
-
28844480321
-
Practice Guidelines Committee, American Association for the Study of Liver Diseases : Management of hepatocellular carcinoma
-
Bruix J, Sherman M : Practice Guidelines Committee, American Association for the Study of Liver Diseases : Management of hepatocellular carcinoma. Hepatology 2005 ; 42 : 1208-36
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
22
-
-
0029858542
-
Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis
-
Zoli M, Merkel C, Magalotti D, Marchesini G, Gatta A, Pisi E : Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology 1996 ; 24 : 1047-52
-
(1996)
Hepatology
, vol.24
, pp. 1047-1052
-
-
Zoli, M.1
Merkel, C.2
Magalotti, D.3
Marchesini, G.4
Gatta, A.5
Pisi, E.6
-
24
-
-
33947387582
-
Can we ignore minimal hepatic encephalopathy any longer ?
-
Qadri AM, Ogunwale BO, Mullen KD : Can we ignore minimal hepatic encephalopathy any longer ? Hepatology 2007 ; 45 : 547-8
-
(2007)
Hepatology
, vol.45
, pp. 547-548
-
-
Qadri, A.M.1
Ogunwale, B.O.2
Mullen, K.D.3
-
25
-
-
33846419087
-
Review article : The current pharmacological therapies for hepatic encephalopathy
-
Bass NM : Review article : the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 2007 ; 25 (Suppl 1) : 23-31
-
(2007)
Aliment Pharmacol Ther
, vol.25
, Issue.SUPPL. 1
, pp. 23-31
-
-
Bass, N.M.1
-
26
-
-
14944355175
-
Bacterial infections in cirrhosis : Treatment and prophylaxis
-
Garcia-Tsao G : Bacterial infections in cirrhosis : treatment and prophylaxis. J Hepatol 2005 ; 42 (Suppl 1) : S85-92
-
(2005)
J Hepatol
, vol.42
, Issue.SUPPL. 1
-
-
Garcia-Tsao, G.1
-
27
-
-
33846273496
-
Diagnosis and treatment of acute renal failure in patients with cirrhosis
-
Moreau R, Lebrec D : Diagnosis and treatment of acute renal failure in patients with cirrhosis. Best Pract Res Clin Gastroenterol 2007 ; 21 : 111-23
-
(2007)
Best Pract Res Clin Gastroenterol
, vol.21
, pp. 111-123
-
-
Moreau, R.1
Lebrec, D.2
-
28
-
-
0033057751
-
The risk of surgery in patients with liver disease
-
Friedman LS : The risk of surgery in patients with liver disease. Hepatology 1999 ; 29 : 1617
-
(1999)
Hepatology
, vol.29
, pp. 1617
-
-
Friedman, L.S.1
-
29
-
-
0017383711
-
Preoperative and postoperative care
-
Stone HH : Preoperative and postoperative care. Surg Clin N Am 1977 ; 57 : 409
-
(1977)
Surg Clin N Am
, vol.57
, pp. 409
-
-
Stone, H.H.1
|